Campbell & CO Investment Adviser LLC Editas Medicine, Inc. Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$6.25 - $11.11 $320,631 - $569,954
51,301 New
51,301 $519,000
Q2 2023

Aug 11, 2023
BUY
$6.36 - $11.47 $76,466 - $137,903
12,023 New
12,023 $98,000
Q1 2022

May 09, 2022
SELL
$14.08 - $27.63 $176,704 - $346,756
-12,550 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$26.55 - $40.57 $333,202 - $509,153
12,550 New
12,550 $333,000

Others Institutions Holding EDIT

# of Institutions
248
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $90M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email